Metraipolis › archive › dc_aa702cfaeb6c

Myocarditis and Myasthenia Gravis Induced by Camrelizumab in a Patient With Metastatic B2 Thymoma: A Case Report — Europe PMC PMID:41188194

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41188194
DOI: 10.1111/1759-7714.70180
License (as archived): solo-consultazione
Archived: 2026-11-08T20:50:05.723Z
SHA-256 of the archived text: 209ddfa16b8be4ddf0ffca5549ac5fbf7cfd3ae486038293006a9a3e9b228a65
Stable URL of this page: https://metraipolis.com/documento/dc_aa702cfaeb6c

How to cite

Myocarditis and Myasthenia Gravis Induced by Camrelizumab in a Patient With Metastatic B2 Thymoma: A Case Report — Europe PMC PMID:41188194 — Europe PMC (en), https://europepmc.org/article/MED/41188194 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_aa702cfaeb6c (Metraipolis archive dc_aa702cfaeb6c, sha256 209ddfa16b8be4ddf0ffca5549ac5fbf7cfd3ae486038293006a9a3e9b228a65)

BibTeX

@misc{dcaa702cfaeb6c,
  title = {Myocarditis and Myasthenia Gravis Induced by Camrelizumab in a Patient With Metastatic B2 Thymoma: A Case Report — Europe PMC PMID:41188194},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41188194},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_aa702cfaeb6c; sha256 209ddfa16b8be4ddf0ffca5549ac5fbf7cfd3ae486038293006a9a3e9b228a65},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41188194. Agents can read the archived copy with the MCP tool read_document.